Bayer presents novel adenosine A2B receptor antagonist with potential for lung fibrosis Feb. 28, 2019
Development of a novel quadruple agonist to treat nonalcoholic steatohepatitis and fibrosis Feb. 22, 2019
Afibromer shielded engineered allogeneic cells demonstrate safety and efficacy in hemophilia A model Feb. 19, 2019
Multifunctional carbazole-based dopamine agonists for the treatment of Parkinson's disease Feb. 11, 2019
Targeting NRAS activator STK19 blocks melanocyte malignant transformation and melanoma growth Feb. 8, 2019
GF-1061 shows promising activity against Leishmania infantum and Leishmania amazonensis species Feb. 6, 2019
RSS